UBS AM
KRRO icon

UBS AM’s Korro Bio KRRO Stock Holding History

UBS AM’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.97K Hold
225
– – ﹤0.01% 3485
2026
Q1 		$2.55K Buy
225
+134
+147% +$1.48K ﹤0.01% 3557
2025
Q4 		$729 Buy
+91
New +$2.13K ﹤0.01% 3214
2021
Q4 		– Sell
-810
Closed -$286K – 2882
2021
Q3 		$286K Hold
810
– – ﹤0.01% 2628
2021
Q2 		$403K Buy
810
+488
+152% +$238K ﹤0.01% 2595
2021
Q1 		$153K Buy
322
+12
+4% +$23.3K ﹤0.01% 2580
2020
Q4 		$547K Buy
+310
New +$409K ﹤0.01% 2272

Other funds holding KRRO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

UBS AM's KRRO Position: Q2 2026 in Review

UBS AM held its Korro Bio (KRRO) position steady in Q2 2026 at 225 shares worth $2.97K. The position accounts for ﹤0.01% of the portfolio, ranked #3485.

UBS AM first reported a position in KRRO in Q4 2020 and has held it in 7 quarters since. The position peaked at $547K in Q4 2020. 107 funds tracked by Wall St. Rank hold KRRO as of Q2 2026.

  • UBS AM held 225 shares of Korro Bio worth $2.97K as of Q2 2026.
  • UBS AM left its Korro Bio share count unchanged in Q2 2026.
  • Korro Bio made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #3485 holding.
  • UBS AM first reported a position in Korro Bio in Q4 2020 and has held it in 7 quarters since.
  • UBS AM's Korro Bio position peaked at $547K in Q4 2020.
  • 107 funds tracked by Wall St. Rank held Korro Bio as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.